ACI ITG-5.1-2007
基于验证试验和注释的专用非粘接后张预制结构墙用评估标准

Acceptance Criteria for Special Unbonded Post-Tensioned Precast Structural Walls Based on Validation Testing and Commentary


 

 

非常抱歉,我们暂时无法提供预览,您可以试试: 免费下载 ACI ITG-5.1-2007 前三页,或者稍后再访问。

您也可以尝试购买此标准,
点击右侧 “购买” 按钮开始采购(由第三方提供)。

点击下载后,生成下载文件时间比较长,请耐心等待......

 

标准号
ACI ITG-5.1-2007
发布
2007年
发布单位
美国混凝土学会
 
 
引用标准
ACI 318-2005 ACI T1.1 ACI T1.2 ASCE/SEI 7-2005 ASTM C39/C39M-05 FEMA 356 IBC 2003 NFPA 5000 UBC 1997
适用范围
This document applies to structures in regions of high seismic risk or to structures assigned to high seismic performance or design categories. It defines the minimum experimental evidence that can be deemed to satisfy the use of unbonded post-tensioned precast structural walls (shear walls) for bearing wall and building frame special reinforced concrete shear wall systems, as defined in ASCE/SEI 7-05, when those walls do not fully satisfy the intent of the prescriptive requirements of Chapter 21 of ACI 318-05. This document includes mandatory Acceptance Criteria and nonmandatory Commentary, and has been written in such a form that its requirements can be coordinated directly with the requirements for special precast structural walls in 21.8 of ACI 318-05. Among the subjects covered are requirements for the procedures that shall be used to design unbonded post-tensioned precast test modules and their configurations, as well as requirements for testing, reporting, and assessing satisfactory performance of the test modules. The references of the Commentary provide documentary evidence, additional to the references of Chapter 21 of ACI 318R-05, that support the acceptance criteria. Consistent with the approach of ACI 318, no comparison is made, either in the body of the Acceptance Criteria or Commentary, of research results for precast test modules satisfying ACI 318 with those for modules that, although not satisfying ACI 318, do satisfy the Acceptance Criteria. Such comparisons, both experimental and analytical, are available in the Commentary references. In this document, consistent with the format of ACI 318-05, the word “Section” is not included before a reference to a section of ACI 318-05. To more clearly designate a section in this document, however, the word “Section” is used before any reference to a section of this document. The section numbering for the Commentary is the same as that for the Standard, with numbers preceded by an “R” and the text in italics to distinguish them from the corresponding section numbers of the Standard.

ACI ITG-5.1-2007相似标准


推荐

干货丨装配式建筑迅猛发展,如何解决检测难题?

预制构件实体检验:受力筋数量、规格、间距、保护层厚度、混凝土强度,检验方法宜采用破损法。结构实体检验:混凝土现浇连接部位或者混凝土叠合部位,同现浇混凝土结构检验方法相同。现有质量检验标准存在问题有与连接相关产品检验技术标准,尚无针对装配式结构检测技术标准。而随着装配式建筑大力发展,标准也在逐步完善,如正在修订《建筑结构检测技术标准》将增加装配式结构检测技术。...

总局关于发布药物遗传毒性研究技术指导原则通告(2018年第50号)

除人工镜检方法外,若方法学经过了充分验证,也可采用自动化分析系统(如图像分析系统流式细胞术)对微核进行检测。啮齿类动物给药,取外周血淋巴细胞进行体外培养,也可用于分析染色体畸变(注释10)。 2.2 其他体内遗传毒性试验第二项体内试验可作为第二种标准试验组合一部分,并可用作追加试验以在评价体外或体内试验结果时提高证据权重(注释11)。...

200项行标公示 含无损检测、试验箱等仪器及分析法

根据公示,此次报批200项行业标准具体包括《振动筛 试验方法》等164项机械行业标准、《船舶建造企业能源计量器具配备管理要求》1项船舶行业标准、《化工设备吊耳设计选用规范》等2项化工行业标准、《钻孔注浆连续技术规范》等3项冶金行业标准、《自行车 中轴》等26项轻工行业标准、《运输包装拉伸缠绕膜》1项包装行业标准、《煤矿许瓦斯抽采水胶药柱》等3项民爆。...

公开征求《创新药(化学药)临床试验期间药学变更技术指导原则(征求意见稿)》意见

在药学对比研究结果显示制剂质量存在显著差异,或仅通过药学比较研究无法评估变更对制剂质量潜在影响时,需结合当前临床阶段以及临床试验方案考虑制剂体内桥研究(或)临床安全性研究。对于附带专用溶剂处方变化,需结合其对配伍制剂质量影响进行相关考察。2.2.1重大变更包括但不限于:· 可能对制剂质量产生明显影响处方变化(比如关键辅料种类/型号/用量显著变化等)。...





Copyright ©2007-2022 ANTPEDIA, All Rights Reserved
京ICP备07018254号 京公网安备1101085018 电信与信息服务业务经营许可证:京ICP证110310号